National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for the Use of Tumor Markers

被引:64
作者
Diamandis, Eleftherios P. [2 ,3 ]
Hoffman, Barry R. [2 ,3 ]
Sturgeon, Catharine M. [1 ]
机构
[1] Royal Infirmary Edinburgh, Dept Clin Biochem, Edinburgh, Midlothian, Scotland
[2] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON, Canada
[3] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
关键词
D O I
10.1373/clinchem.2008.105494
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
[No abstract available]
引用
收藏
页码:1935 / 1939
页数:5
相关论文
共 15 条
[1]  
Atkins D, 2004, BMJ-BRIT MED J, V328, P1490
[2]  
Cluzeau F, 2003, QUAL SAF HEALTH CARE, V12, P18
[3]   Sources of bias for authors of clinical practice guidelines [J].
Detsky, Allan S. .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2006, 175 (09) :1033-1033
[4]  
Fleisher M, 2002, Tumor markers: physiology, pathobiology, technology, and clinical applications, P33
[5]   Tumor marker utility grading system: A framework to evaluate clinical utility of tumor markers [J].
Hayes, DF ;
Bast, RC ;
Desch, CE ;
Fritsche, H ;
Kemeny, NE ;
Jessup, JM ;
Locker, GY ;
MacDonald, JS ;
Mennel, RG ;
Norton, L ;
Ravdin, P ;
Taube, S ;
Winn, RJ .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (20) :1456-1466
[6]   Prognostic and predictive factors for breast cancer: Translating technology to oncology [J].
Hayes, DF .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (08) :1596-1597
[7]   Evidence-based guidelines in laboratory medicine: Principles and methods [J].
Oosterhuis, WP ;
Bruns, DE ;
Watine, J ;
Sandberg, S ;
Horvath, AR .
CLINICAL CHEMISTRY, 2004, 50 (05) :806-818
[8]  
PENTHEROUDAKIS G, ANN ONCOL UNPUB
[9]  
PRICE CP, 2007, EVIDENCE BASED LAB
[10]  
*SIGN, 1998, MANAG ADULT TESTIC